Menu

Blog

Aug 31, 2021

Specially designed monoclonal antibodies may prevent celiac disease, study finds

Posted by in category: biotech/medical

A good start if you are a sufferer. There are many studies and trials for working toward a cure. Keep searching.


Aug. 20 (UPI) — Antibody therapy may help prevent the development of celiac disease, the digestive disorder that limits the body’s ability to process foods that contain wheat, barley and rye, a study published Friday by Science Immunology found.

The approach uses specially modified monoclonal, or laboratory-created, antibodies that prevent the human immune system from recognizing gluten, a protein found in these foods, as a toxin, the researchers said.

This means that T cells, which, like antibodies, are cells created by the immune system to fight off invading diseases or toxins, will not respond to gluten and allow the body to digest or process it, according to the researchers.

Leave a reply